New York State Common Retirement Fund
MIRM icon

New York State Common Retirement Fund’s Mirum Pharmaceuticals MIRM Stock Holding History

New York State Common Retirement Fund’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29.3M Buy
250,558
+49,413
+25% +$4.96M 0.04% 344
2026
Q1 		$18.6M Sell
201,145
-16,461
-8% -$1.55M 0.03% 453
2025
Q4 		$17.2M Sell
217,606
-25,781
-11% -$1.85M 0.02% 488
2025
Q3 		$17.8M Sell
243,387
-6,470
-3% -$411K 0.02% 498
2025
Q2 		$12.7M Sell
249,857
-10,509
-4% -$468K 0.02% 641
2025
Q1 		$11.7M Buy
260,366
+32,015
+14% +$1.51M 0.02% 636
2024
Q4 		$9.44M Hold
228,351
– – 0.01% 811
2024
Q3 		$8.91M Buy
228,351
+38,226
+20% +$1.52M 0.01% 842
2024
Q2 		$6.5M Sell
190,125
-6,554
-3% -$172K 0.01% 998
2024
Q1 		$4.94M Sell
196,679
-26,185
-12% -$720K 0.01% 1120
2023
Q4 		$6.58M Buy
222,864
+918
+0.4% +$27.8K 0.01% 1018
2023
Q3 		$7.01M Buy
221,946
+12,694
+6% +$348K 0.01% 973
2023
Q2 		$5.41M Buy
209,252
+197,154
+1,630% +$5.24M 0.01% 1133
2023
Q1 		$291K Buy
12,098
+933
+8% +$21.3K ﹤0.01% 2439
2022
Q4 		$218K Sell
11,165
-8
-0.1% -$158 ﹤0.01% 2687
2022
Q3 		$235K Buy
11,173
+131
+1% +$3.15K ﹤0.01% 2699
2022
Q2 		$215K Buy
11,042
+9,592
+662% +$226K ﹤0.01% 2768
2022
Q1 		$32K Sell
1,450
-4,000
-73% -$81.6K ﹤0.01% 3245
2021
Q4 		$87K Hold
5,450
– – ﹤0.01% 3112
2021
Q3 		$109K Sell
5,450
-12
-0.2% -$195 ﹤0.01% 3113
2021
Q2 		$94K Buy
5,462
+50
+0.9% +$896 ﹤0.01% 3217
2021
Q1 		$107K Hold
5,412
– – ﹤0.01% 3049
2020
Q4 		$94K Hold
5,412
– – ﹤0.01% 3044
2020
Q3 		$104K Buy
5,412
+2,300
+74% +$49.4K ﹤0.01% 2905
2020
Q2 		$61K Buy
3,112
+1,500
+93% +$25.1K ﹤0.01% 3129
2020
Q1 		$23K Hold
1,612
– – ﹤0.01% 3094
2019
Q4 		$40K Sell
1,612
-4,300
-73% -$45.8K ﹤0.01% 3146
2019
Q3 		$59K Buy
+5,912
New +$72.5K ﹤0.01% 3144

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

New York State Common Retirement Fund's MIRM Position: Q2 2026 in Review

New York State Common Retirement Fund increased its Mirum Pharmaceuticals (MIRM) stake by 25% in Q2 2026, buying an estimated $4.96M and bringing the position to 250,558 shares worth $29.3M. The position accounts for 0.04% of the portfolio, ranked #344.

New York State Common Retirement Fund first reported a position in MIRM in Q3 2019 and has held it in 28 quarters since. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • New York State Common Retirement Fund held 250,558 shares of Mirum Pharmaceuticals worth $29.3M as of Q2 2026.
  • New York State Common Retirement Fund bought 49,413 Mirum Pharmaceuticals shares in Q2 2026, an estimated $4.96M.
  • Mirum Pharmaceuticals made up 0.04% of New York State Common Retirement Fund's portfolio in Q2 2026, its #344 holding.
  • New York State Common Retirement Fund first reported a position in Mirum Pharmaceuticals in Q3 2019 and has held it in 28 quarters since.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.